Pricing Log in Create free account

CG Oncology, Inc. (CGON) vs Cogent Biosciences, Inc. (COGT)

CG Oncology, Inc. and Cogent Biosciences, Inc. are both Biotechnology companies. CG Oncology, Inc. is the larger, with a market value of $5.7B against $5.1B — 1.1× the size. CG Oncology, Inc. grew revenue faster over the last twelve months: 178.1% against 110.2%. Cogent Biosciences, Inc. has the higher net margin (0.00% vs −3,851.1%) and the higher return on invested capital (0.00% vs −1,740.2%). Across the 16 metrics below, CG Oncology, Inc. leads on 8 and Cogent Biosciences, Inc. on 8.

Valuation

Metric CGON COGT Biotechnology median
P/E n/m n/m 10.60
P/S 1,096.55 233.33 9.40
P/B 6.82 11.56 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 938.83 208.77 9.02
Earnings yield (3.63%) (6.84%) (32.88%)
Free cash flow yield (2.80%) (5.72%) (23.13%)

Profitability

Metric CGON COGT Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin (4,293.53%) 0.00% 0.00%
Net margin (3,851.09%) 0.00% 0.00%
Free cash flow margin (3,068.02%) 0.00% 0.00%
Return on equity (28.29%) (146.55%) (51.96%)
Return on assets (26.73%) (68.00%) (46.06%)
Return on invested capital (1,740.24%) 0.00% 0.00%

Growth

Metric CGON COGT Biotechnology median
Revenue growth (TTM) 178.12% 110.23% 6.76%
EPS growth (last fiscal year) (47.52%) (11.34%) 29.88%
Revenue growth, 5-year CAGR — 21.39% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CGON COGT Biotechnology median
Debt to equity 0.00 0.42 0.00
Current ratio 21.70 13.57 4.97
Net debt to EBITDA 3.88 2.04 1.01

Dividend

Metric CGON COGT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CGON COGT Biotechnology median
Market cap 5.74b 5.13b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack